01Sensors
DNA is damaged thousands of times a day. Checkpoints pause the cycle so repair can happen. Two master kinases sense trouble: ATM responds mainly to double-strand breaks, while ATR responds to single-stranded DNA and stalled replication forks.
They phosphorylate the effector kinases Chk2 (from ATM) and Chk1 (from ATR), which in turn inactivate Cdc25 phosphatases — so CDKs stay inhibited and the cycle halts.
02p53: the guardian of the genome
ATM and Chk2 also phosphorylate p53, stabilizing it. Normally p53 is kept low by MDM2, an E3 ubiquitin ligase that tags it for destruction. Damage-induced phosphorylation blocks MDM2 binding, so p53 accumulates.
p53 is a transcription factor. It turns on p21 (cell-cycle arrest), DNA-repair genes, and — if damage is too severe — pro-apoptotic genes like PUMA, NOXA and BAX. It decides between 'pause and fix' and 'self-destruct'.
03Why checkpoint loss fuels cancer
TP53 is mutated in roughly half of all human cancers. Without p53, damaged cells keep dividing, accumulating more mutations — a vicious cycle called genomic instability.
Inherited mutation of one TP53 copy causes Li-Fraumeni syndrome, with high risk of many cancers early in life. Inherited ATM loss causes ataxia-telangiectasia with radiation sensitivity and cancer predisposition.